Essential hypertension
Hypertension can be divided into two categories: primary and secondary. In the vast majority of patients, the cause of hypertension is unknown, which is called primary hypertension, accounting for more than 95% of all hypertensive patients; primary hypertension, also known as hypertension, can cause symptoms related to hypertension itself. Long-term hypertension can also become an important risk factor for a variety of cardiovascular and cerebrovascular diseases, and affect the functions of important organs such as the heart, brain, and kidneys, and eventually lead to the failure of these organs.
Related Drugs
CARVEDILOL- carvedilol_tablet, film coated
Indication: Carvedilol is an alpha-/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure ( 1. 1 left ventricular dysfunction following myocardial infarction in clinically stable patients ( 1. 2 hypertension ( 1. 3 Carvedilol is indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization [see Drug Interactions ( 7. 1 Carvedilol is indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of less than or equal to 40% (with or without symptomatic heart failure) [see Clinical Studies ( 14. 2 Carvedilol is indicated for the management of essential hypertension [see Clinical Studies ( 14. 4 [see Drug Interactions ( 7.
Manufacturer:
REMEDYREPACK INC.
CARVEDILOL- carvedilol_tablet, film coated
Indication: Carvedilol is an alpha-/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure ( 1. 1 left ventricular dysfunction following myocardial infarction in clinically stable patients (1. 2) hypertension (1. 3) Carvedilol tablets are indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization [see Drug Interactions (7. 4) , Clinical Studies (14. 1) ] Carvedilol tablets are indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of less than or equal to 40% (with or without symptomatic heart failure) [see Clinical Studies (14. 2) Carvedilol tablets are indicated for the management of essential hypertension [see Clinical Studies (14. 4) [see Drug Interactions (7.
Manufacturer:
REMEDYREPACK INC.
CARVEDILOL- carvedilol_tablet, film coated
Indication: Carvedilol is an alpha-/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure ( 1. 1 left ventricular dysfunction following myocardial infarction in clinically stable patients (1. 2) hypertension (1. 3) Carvedilol tablets are indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization [see Drug Interactions (7. 4) , Clinical Studies (14. 1) ] Carvedilol tablets are indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of less than or equal to 40% (with or without symptomatic heart failure) [see Clinical Studies (14. 2) Carvedilol tablets are indicated for the management of essential hypertension [see Clinical Studies (14. 4) [see Drug Interactions (7.
Manufacturer:
REMEDYREPACK INC.
COREG- carvedilol_tablet, film coated
Indication: COREG is an alpha-/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure ( 1. 1 left ventricular dysfunction following myocardial infarction in clinically stable patients ( 1. 2 hypertension ( 1. 3 COREG is indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization [see Drug Interactions (7. 4) Clinical Studies (14. 1) COREG is indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of less than or equal to 40% (with or without symptomatic heart failure) [see Clinical Studies (14. 2) COREG is indicated for the management of essential hypertension [see Clinical Studies (14. 4) [see Drug Interactions (7.
Manufacturer:
Woodward Pharma Services LLC